{{Rsnum
|rsid=3769825
|Gene=CASP8
|Chromosome=2
|position=201246657
|Orientation=minus
|GMAF=0.3898
|Gene_s=CASP8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 24.8 | 47.8 | 27.4
| HCB | 1.5 | 36.5 | 62.0
| JPT | 6.2 | 34.5 | 59.3
| YRI | 8.8 | 50.3 | 40.8
| ASW | 5.3 | 52.6 | 42.1
| CHB | 1.5 | 36.5 | 62.0
| CHD | 4.6 | 28.4 | 67.0
| GIH | 4.0 | 35.6 | 60.4
| LWK | 12.8 | 49.5 | 37.6
| MEX | 22.4 | 56.9 | 20.7
| MKK | 21.6 | 52.3 | 26.1
| TSI | 28.4 | 47.1 | 24.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23770605
  |Trait=Chronic lymphocytic leukemia
  |Title=Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
  |RiskAllele=T
  |Pval=3E-9
  |OR=1.19
  |ORtxt=[1.12-1.25]
  |OA=1
}}

{{PMID Auto
|PMID=19318553
|Title=A breast cancer risk haplotype in the caspase-8 gene.
|OA=1
}}

{{PMID Auto
|PMID=19414860
|Title=Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|OA=1
}}

{{PMID Auto
|PMID=19531679
|Title=Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.
|OA=1
}}

{{PMID Auto
|PMID=19938081
|Title=Altered transmission of HOX and apoptotic SNPs identify a potential common pathway for clubfoot.
|OA=1
}}

{{PMID Auto
|PMID=22843554
|Title=Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}